Genetic variants in MIR2113 and MIR129-LEP are associated with the susceptibility of COPD in the Chinese Han population
Pulmonary Pharmacology & Therapeutics · 2020-10 · 64 · 101945
DOI: 10.1016/j.pupt.2020.101945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pulmonary Pharmacology & Therapeutics, 2020-10. Verfasst von Jing Jing und 5 weiteren Autor:innen. Beteiligte Einrichtung: COPD Laboratory of Clinical Research Center, Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Urumqi, Xinjiang, 830099, PR …. Hauptthemen laut MEDLINE: MicroRNAs, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: State Administration of Traditional Chinese Medicine.
Themen: COPD
Abstract (Originalsprache)
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is the result of interaction between genetic and environmental factors. In this study, we aimed to explore whether MIR2113 and MIR129-LEP polymorphisms confer susceptibility to COPD. METHODS: We selected five polymorphisms of two genes (MIR2113: rs2505059 and rs9320913; MIR129-LEP: rs7778167, rs791595 and rs4731420) based on previous studies and genotyped 629 samples, which included 315 COPD patients and 314 controls with Agena MassARRAY platform. The association of MIR2113 and MIR129-LEP polymorphisms with COPD risk was conducted with logistic regression by calculating odd ratios (OR) and 95% confidence intervals (CI). RESULTS: MIR2113 rs2505059 was remarkably linked with a decreased susceptibility of COPD in five genetic models, whereas MIR2113 rs9320913, MIR129-LEP rs791595 and MIR129-LEP rs4731420 could enhance the susceptibility of COPD in the Chinese Han population (P < 0.05). Stratified analysis revealed that the influences of genetic variants on COPD risk were dependent on age, sex, Body mass index or smoking status (P < 0.05). Haplotype analysis showed that Ars791595Crs4731420 haplotype significant increased the susceptibility of COPD. CONCLUSION: It suggested that polymorphisms of MIR2113 and MIR129-LEP might be linked with the susceptibility of COPD among the Chinese Han population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- COPD Laboratory of Clinical Research Center, Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Urumqi, Xinjiang, 830099, PR China. Electronic address: 37421380@qq.com.
- COPD Laboratory of Clinical Research Center, Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Urumqi, Xinjiang, 830099, PR China.
- Clinical Research Center, Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Urumqi, Xinjiang, 830099, PR China.
- Department of Respiratory Intensive Care, Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine, Urumqi, Xinjiang, 830099, PR China.
Förderung
- State Administration of Traditional Chinese Medicine
Zitieren
APA
Jing, J., Xu, D., Li, Z., Jiang, M., Wang, J., & Zhang, J. (2020). Genetic variants in MIR2113 and MIR129-LEP are associated with the susceptibility of COPD in the Chinese Han population. Pulmonary Pharmacology & Therapeutics, 64, 101945. https://doi.org/10.1016/j.pupt.2020.101945
Vancouver
Jing J, Xu D, Li Z, Jiang M, Wang J, Zhang J. Genetic variants in MIR2113 and MIR129-LEP are associated with the susceptibility of COPD in the Chinese Han population. Pulmonary Pharmacology & Therapeutics. 2020;64:101945. doi:10.1016/j.pupt.2020.101945
BibTeX
@article{Jing2020,
author = {Jing, Jing and Xu, Dan and Li, Zheng and Jiang, Min and Wang, Jing and Zhang, Jian},
title = {Genetic variants in MIR2113 and MIR129-LEP are associated with the susceptibility of COPD in the Chinese Han population},
journal = {Pulmonary Pharmacology & Therapeutics},
year = {2020},
volume = {64},
pages = {101945},
doi = {10.1016/j.pupt.2020.101945}
}
EUVIMED